Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Vanta Bioscience Limited
  6. News
  7. Summary
    540729   INE695X01011

VANTA BIOSCIENCE LIMITED

(540729)
  Report
End-of-day quote Bombay Stock Exchange  -  05-26
99.30 INR   -4.98%
01/04Vanta Bioscience to Conduct Animal and Agrochem Studies for Coromandel International
MT
01/04Vanta Bioscience Limited Receives Order of INR 11.8 Million from Coromandel International Limited
CI
2021Vanta Bioscience Limited Announces CFO Changes
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Vanta Bioscience to Conduct Animal and Agrochem Studies for Coromandel International

01/04/2022 | 04:14am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
COROMANDEL INTERNATIONAL LIMITED 2.07% 938.8 Delayed Quote.21.65%
VANTA BIOSCIENCE LIMITED -4.98% 99.3 End-of-day quote.-21.66%
All news about VANTA BIOSCIENCE LIMITED
01/04Vanta Bioscience to Conduct Animal and Agrochem Studies for Coromandel International
MT
01/04Vanta Bioscience Limited Receives Order of INR 11.8 Million from Coromandel Internation..
CI
2021Vanta Bioscience Limited Announces CFO Changes
CI
2021Vanta Bioscience Limited Reports Earnings Results for the Half Year Ended September 30,..
CI
2021VANTA BIOSCIENCE : Receives Full Accreditation from AAALAC Council
MT
2021VANTA BIOSCIENCE : Gains Indian Accreditation to Board's Recommendation to Continue Biolog..
MT
2021Vanta Bioscience Limited Reports Earnings Results for the Full Year Ended March 31, 202..
CI
2021Vanta Bioscience Limited Announces Resignation of Sadhanala Venkata Rao as CEO
CI
2021Vanta Bioscience Limited Announces Resignation of Sadhanala Venkata Rao as Director
CI
2020Vanta Bioscience Limited Reports Earnings Results for the Half Year Ended September 30,..
CI
More news
Financials
Sales 2021 100 M 1,29 M 1,29 M
Net income 2021 4,50 M 0,06 M 0,06 M
Net Debt 2021 333 M 4,30 M 4,30 M
P/E ratio 2021 229x
Yield 2021 -
Capitalization 627 M 8,08 M 8,08 M
EV / Sales 2020 5,28x
EV / Sales 2021 13,6x
Nbr of Employees 56
Free-Float 28,5%
Chart VANTA BIOSCIENCE LIMITED
Duration : Period :
Vanta Bioscience Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Dopesh Raja Mulakala Executive Director
A. Kiran Kumar Chief Financial Officer
Mohan Krishna Mulakala Non-Executive Chairman
Vyasmurti Madhavrao Shingatgeri Executive Director & Chief Scientific Officer
Zoheb Sayani Secretary & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
VANTA BIOSCIENCE LIMITED-21.66%8
MODERNA, INC.-46.53%54 016
LONZA GROUP AG-28.07%42 292
IQVIA HOLDINGS INC.-26.37%39 319
SEAGEN INC.-10.44%25 487
ICON PUBLIC LIMITED COMPANY-29.73%17 693